Ryder SA - Search Results

1

Pharmacological effects of a novel isosorbide-based butyrylcholinesterase inhibitor.

Khan D, Gilmer JF, Carolan CG, Gaynor JM, Ryder SA. Khan D, et al. Among authors: ryder sa. Chem Biol Interact. 2008 Sep 25;175(1-3):231-4. doi: 10.1016/j.cbi.2008.05.024. Epub 2008 May 23. Chem Biol Interact. 2008. PMID: 18606399

2

Single oral dose study of two isosorbide-based aspirin prodrugs in the dog.

Gilmer JF, Murphy MA, Shannon JA, Breen CG, Ryder SA, Clancy JM. Gilmer JF, et al. Among authors: ryder sa. J Pharm Pharmacol. 2003 Oct;55(10):1351-7. doi: 10.1211/0022357022007. J Pharm Pharmacol. 2003. PMID: 14607016

3

Novel isosorbide di-ester compounds as inhibitors of acetylcholinesterase.

Carolan CG, Gaynor JM, Dillon GP, Khan D, Ryder SA, Reidy S, Gilmer JF. Carolan CG, et al. Among authors: ryder sa. Chem Biol Interact. 2008 Sep 25;175(1-3):293-7. doi: 10.1016/j.cbi.2008.05.013. Epub 2008 May 18. Chem Biol Interact. 2008. PMID: 18571631

4

Isosorbide-2-carbamate esters: potent and selective butyrylcholinesterase inhibitors.

Carolan CG, Dillon GP, Gaynor JM, Reidy S, Ryder SA, Khan D, Marquez JF, Gilmer JF. Carolan CG, et al. Among authors: ryder sa. J Med Chem. 2008 Oct 23;51(20):6400-9. doi: 10.1021/jm800564y. Epub 2008 Sep 26. J Med Chem. 2008. PMID: 18817366

5

Isosorbide-2-benzyl carbamate-5-salicylate, a peripheral anionic site binding subnanomolar selective butyrylcholinesterase inhibitor.

Carolan CG, Dillon GP, Khan D, Ryder SA, Gaynor JM, Reidy S, Marquez JF, Jones M, Holland V, Gilmer JF. Carolan CG, et al. Among authors: ryder sa. J Med Chem. 2010 Feb 11;53(3):1190-9. doi: 10.1021/jm9014845. J Med Chem. 2010. PMID: 20067290

6

Isosorbide-based cholinesterase inhibitors; replacement of 5-ester groups leading to increased stability.

Dillon GP, Gaynor JM, Khan D, Carolan CG, Ryder SA, Marquez JF, Reidy S, Gilmer JF. Dillon GP, et al. Among authors: ryder sa. Bioorg Med Chem. 2010 Feb;18(3):1045-53. doi: 10.1016/j.bmc.2009.12.052. Epub 2010 Jan 6. Bioorg Med Chem. 2010. PMID: 20093035

7

N1-dansyl-spermine: a potent polyamine antagonist.

Kirby BP, Ryder SA, Seiler N, Renault J, Shaw GG. Kirby BP, et al. Among authors: ryder sa. Brain Res. 2004 Jun 11;1011(1):69-73. doi: 10.1016/j.brainres.2004.02.075. Brain Res. 2004. PMID: 15140645

8

Tumour vasculature targeting agents in hybrid/conjugate drugs.

Prokopiou EM, Ryder SA, Walsh JJ. Prokopiou EM, et al. Among authors: ryder sa. Angiogenesis. 2013 Jul;16(3):503-24. doi: 10.1007/s10456-013-9347-8. Epub 2013 Mar 31. Angiogenesis. 2013. PMID: 23543223 Review.

9

Profiling harmful medication errors in an acute Irish teaching hospital.

Relihan EC, Ryder SA, Silke B. Relihan EC, et al. Among authors: ryder sa. Ir J Med Sci. 2012 Dec;181(4):491-7. doi: 10.1007/s11845-012-0804-y. Epub 2012 Jan 26. Ir J Med Sci. 2012. PMID: 22278633

10

Design and Implementation of an Integrated Competency-Focused Pharmacy Programme: A Case Report.

Ryan TJ, Grimes T, Henman MC, Sheachnasaigh EN, O'Dwyer M, Roche C, Ryder SA, Sasse A, Walsh JJ, D'Arcy DM. Ryan TJ, et al. Among authors: ryder sa. Pharmacy (Basel). 2019 Aug 27;7(3):121. doi: 10.3390/pharmacy7030121. Pharmacy (Basel). 2019. PMID: 31461883 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

26 results

Search Page

Filters